Richard D. Lozano

2.4k total citations
23 papers, 1.8k citations indexed

About

Richard D. Lozano is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Richard D. Lozano has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Richard D. Lozano's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Richard D. Lozano is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Richard D. Lozano collaborates with scholars based in United States, Paraguay and Guatemala. Richard D. Lozano's co-authors include Yehuda Z. Patt, Manal M. Hassan, Steven A. Curley, Robert A. Wolff, Jean‐Nicolas Vauthey, Douglas B. Evans, Jaffer A. Ajani, Paulo M. Hoff, Maria A. Kouvaraki and James C. Yao and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

Richard D. Lozano

23 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Lozano United States 19 865 806 556 432 395 23 1.8k
H. O. Douglass United States 17 1.0k 1.2× 320 0.4× 115 0.2× 390 0.9× 273 0.7× 48 1.6k
Shinichi Ohkawa Japan 24 1.2k 1.4× 697 0.9× 756 1.4× 631 1.5× 339 0.9× 96 2.3k
Skye C. Mayo United States 24 1.5k 1.7× 363 0.5× 808 1.5× 959 2.2× 293 0.7× 93 2.3k
Roland Sonntag Switzerland 20 471 0.5× 286 0.4× 113 0.2× 732 1.7× 485 1.2× 48 1.5k
Yangsoon Park South Korea 20 475 0.5× 244 0.3× 176 0.3× 301 0.7× 279 0.7× 59 1.2k
Natsuko Okita Japan 20 855 1.0× 236 0.3× 91 0.2× 271 0.6× 278 0.7× 110 1.3k
Joji Yamamoto Japan 17 337 0.4× 160 0.2× 309 0.6× 381 0.9× 171 0.4× 39 997
T Kosuge Japan 18 489 0.6× 567 0.7× 865 1.6× 675 1.6× 144 0.4× 51 1.6k
Raphael Mohr Germany 18 307 0.4× 311 0.4× 290 0.5× 176 0.4× 189 0.5× 70 942
Francesca Del Monte Italy 17 458 0.5× 149 0.2× 112 0.2× 101 0.2× 306 0.8× 27 1.0k

Countries citing papers authored by Richard D. Lozano

Since Specialization
Citations

This map shows the geographic impact of Richard D. Lozano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Lozano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Lozano more than expected).

Fields of papers citing papers by Richard D. Lozano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Lozano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Lozano. The network helps show where Richard D. Lozano may publish in the future.

Co-authorship network of co-authors of Richard D. Lozano

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Lozano. A scholar is included among the top collaborators of Richard D. Lozano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Lozano. Richard D. Lozano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lozano, Richard D., et al.. (2014). Successful Implementation of Station Platform Between Car Barriers. Transportation Research Board 93rd Annual MeetingTransportation Research Board. 1 indexed citations
2.
3.
Lowry, Ashley M., Russell E. Lewis, Richard D. Lozano, et al.. (2011). Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma. Journal of Antimicrobial Chemotherapy. 67(2). 422–429. 5 indexed citations
4.
5.
Hassan, Manal M., Steven A. Curley, Donghui Li, et al.. (2010). Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer. 116(8). 1938–1946. 246 indexed citations
6.
Lozano, Richard D., Thomas D. Brown, Yehuda Z. Patt, et al.. (2008). A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 134(12). 1325–1335. 21 indexed citations
7.
Hassan, Manal M., Melanie B. Thomas, Steven A. Curley, et al.. (2008). The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States. Journal of Hepatology. 50(2). 334–341. 64 indexed citations
8.
Hassan, Manal M., Margaret R. Spitz, Melanie B. Thomas, et al.. (2008). Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study. International Journal of Cancer. 123(8). 1883–1891. 64 indexed citations
9.
Hassan, Manal M., Ahmed O. Kaseb, Donghui Li, et al.. (2008). Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States #. Hepatology. 49(5). 1563–1570. 134 indexed citations
10.
Thomas, Melanie B., Eric D. Tetzlaff, Richard D. Lozano, et al.. (2007). Curing hepatocellular carcinomatosis with biologic therapy and surgery: Achieving the impossible?. Journal of Surgical Oncology. 97(1). 82–84. 4 indexed citations
11.
Patt, Yehuda Z., Manal M. Hassan, Richard D. Lozano, et al.. (2005). Thalidomide in the treatment of patients with hepatocellular carcinoma. Cancer. 103(4). 749–755. 75 indexed citations
12.
Patt, Yehuda Z., Manal M. Hassan, Álvaro Aguayo, et al.. (2004). Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer. 101(3). 578–586. 145 indexed citations
13.
Scaife, Courtney L., Steven A. Curley, Francesco Izzo, et al.. (2003). Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer. Annals of Surgical Oncology. 10(4). 348–354. 36 indexed citations
14.
Patt, Yehuda Z., Manal M. Hassan, Richard D. Lozano, et al.. (2001). Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.. PubMed. 7(11). 3375–80. 72 indexed citations
15.
Pro, Barbara, et al.. (2001). Therapeutic Response to Octreotide in Patients with Refractory CPT-11 Induced Diarrhea. Investigational New Drugs. 19(4). 341–343. 17 indexed citations
16.
Patt, Yehuda Z., et al.. (2000). Durable Clinical Response of Refractory Hepatocellular Carcinoma to Orally Administered Thalidomide. American Journal of Clinical Oncology. 23(3). 319–319. 56 indexed citations
17.
Patt, Yehuda Z., Ashraful Hoque, Mark S. Roh, et al.. (1999). Durable Clinical and Pathologic Response of Hepatocellular Carcinoma to Systemic and Hepatic Arterial Administration of Platinol, Recombinant Interferon α 2B, Doxorubicin, and 5-Fluorouracil. American Journal of Clinical Oncology. 22(2). 209–213. 22 indexed citations
18.
Patt, Yehuda Z., Ashraful Hoque, Richard D. Lozano, et al.. (1997). Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.. Journal of Clinical Oncology. 15(4). 1432–1438. 23 indexed citations
19.
Patt, Yehuda Z., et al.. (1996). Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.. Journal of Clinical Oncology. 14(8). 2311–2315. 91 indexed citations
20.
Lozano, Richard D., et al.. (1996). Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.. Journal of Clinical Oncology. 14(8). 2306–2310. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. O. Douglass Breakdown of academic impact, for papers by Shinichi Ohkawa Breakdown of academic impact, for papers by Skye C. Mayo Breakdown of academic impact, for papers by Roland Sonntag Breakdown of academic impact, for papers by Yangsoon Park Breakdown of academic impact, for papers by Natsuko Okita Breakdown of academic impact, for papers by Joji Yamamoto Breakdown of academic impact, for papers by T Kosuge Breakdown of academic impact, for papers by Raphael Mohr Breakdown of academic impact, for papers by Francesca Del Monte
Rankless by CCL
2026